On the deal, Linklaters and Kirkland & Ellis advised Novo Holdings; Goodwin advised TA Associates. Novo Holdings, a holding and investment company responsible for managing the...
You must be a Standard 1 Year member to access this content.
Covington & Burling advised Bristol Myers Squibb on the deal, and Goodwin Procter advised 2seventy bio. Bristol Myers Squibb (NYSE: BMY) (“BMS”) announced its merger agreement...
You must be a Standard 1 Year member to access this content.
Kirkland & Ellis advised Clearwater Analytics, Goodwin Procter advised Enfusion, and Dechert advised the Special Committee of Enfusion on the deal. Clearwater Analytics (NYSE: CWAN), a...
You must be a Standard 1 Year member to access this content.
Gibson, Dunn & Crutcher advised Jade Biosciences on the transaction, and Cooley advised the placement agents; while Goodwin Procter advised Aerovate Therapeutics, Inc. Aerovate Therapeutics, Inc....
You must be a Standard 1 Year member to access this content.
